215 related articles for article (PubMed ID: 27425382)
1. Serum N-Terminal Type III Procollagen Propeptide: An Indicator of Growth Hormone Excess and Response to Treatment in Feline Hypersomatotropism.
Keyte SV; Kenny PJ; Forcada Y; Church DB; Niessen SJ
J Vet Intern Med; 2016 Jul; 30(4):973-82. PubMed ID: 27425382
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and diagnostic potential of serum ghrelin in feline hypersomatotropism and diabetes mellitus.
Jensen KB; Forcada Y; Church DB; Niessen SJ
J Vet Intern Med; 2015 Jan; 29(1):14-20. PubMed ID: 25619512
[TBL] [Abstract][Full Text] [Related]
3. Screening diabetic cats for hypersomatotropism: performance of an enzyme-linked immunosorbent assay for insulin-like growth factor 1.
Rosca M; Forcada Y; Solcan G; Church DB; Niessen SJ
J Feline Med Surg; 2014 Feb; 16(2):82-8. PubMed ID: 23828811
[TBL] [Abstract][Full Text] [Related]
4. Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism.
Gostelow R; Scudder C; Keyte S; Forcada Y; Fowkes RC; Schmid HA; Church DB; Niessen SJ
J Vet Intern Med; 2017 Mar; 31(2):355-364. PubMed ID: 28145031
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of hypophysectomy for treatment of hypersomatotropism in 25 cats.
van Bokhorst KL; Galac S; Kooistra HS; Valtolina C; Fracassi F; Rosenberg D; Meij BP
J Vet Intern Med; 2021 Mar; 35(2):834-842. PubMed ID: 33621385
[TBL] [Abstract][Full Text] [Related]
6. Measurements of growth hormone and insulin-like growth factor 1 in cats with diabetes mellitus.
Reusch CE; Kley S; Casella M; Nelson RW; Mol J; Zapf J
Vet Rec; 2006 Feb; 158(6):195-200. PubMed ID: 16474053
[TBL] [Abstract][Full Text] [Related]
7. Elite volunteer athletes of different sport disciplines may have elevated baseline GH levels divorced from unaltered levels of both IGF-I and GH-dependent bone and collagen markers: a study on-the-field.
Sartorio A; Marazzi N; Agosti F; Faglia G; Corradini C; De Palo E; Cella S; Rigamonti A; Muller EE
J Endocrinol Invest; 2004 May; 27(5):410-5. PubMed ID: 15279071
[TBL] [Abstract][Full Text] [Related]
8. Computed tomographic signs of acromegaly in 68 diabetic cats with hypersomatotropism.
Lamb CR; Ciasca TC; Mantis P; Forcada Y; Potter M; Church DB; Niessen SJ
J Feline Med Surg; 2014 Feb; 16(2):99-108. PubMed ID: 23847300
[TBL] [Abstract][Full Text] [Related]
9. Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy.
Tapanainen P; Risteli L; Knip M; Käär ML; Risteli J
J Clin Endocrinol Metab; 1988 Dec; 67(6):1244-9. PubMed ID: 3192681
[TBL] [Abstract][Full Text] [Related]
10. Hypersomatotropism in 3 Cats without Concurrent Diabetes Mellitus.
Fletcher JM; Scudder CJ; Kiupel M; Pipe-Martin HN; Kenny PJ; Mantis P; Fenn J; Smith K; Blair RV; Granger LA; Niessen SJ
J Vet Intern Med; 2016 Jul; 30(4):1216-21. PubMed ID: 27255700
[No Abstract] [Full Text] [Related]
11. Efficacy of hypophysectomy for the treatment of hypersomatotropism-induced diabetes mellitus in 68 cats.
Fenn J; Kenny PJ; Scudder CJ; Hazuchova K; Gostelow R; Fowkes RC; Forcada Y; Church DB; Niessen SJM
J Vet Intern Med; 2021 Mar; 35(2):823-833. PubMed ID: 33624865
[TBL] [Abstract][Full Text] [Related]
12. Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal.
Parkinson C; Kassem M; Heickendorff L; Flyvbjerg A; Trainer PJ
J Clin Endocrinol Metab; 2003 Dec; 88(12):5650-5. PubMed ID: 14671148
[TBL] [Abstract][Full Text] [Related]
13. Serum insulin-like growth factor-I concentration in cats with diabetes mellitus and acromegaly.
Berg RI; Nelson RW; Feldman EC; Kass PH; Pollard R; Refsal KR
J Vet Intern Med; 2007; 21(5):892-8. PubMed ID: 17939540
[TBL] [Abstract][Full Text] [Related]
14. Studying Cat (Felis catus) Diabetes: Beware of the Acromegalic Imposter.
Niessen SJ; Forcada Y; Mantis P; Lamb CR; Harrington N; Fowkes R; Korbonits M; Smith K; Church DB
PLoS One; 2015; 10(5):e0127794. PubMed ID: 26023776
[TBL] [Abstract][Full Text] [Related]
15. Regulation of insulin-like growth factor-binding protein-3 ternary complex in feline diabetes mellitus.
Lewitt MS; Hazel SJ; Church DB; Watson AD; Powell SE; Tan K
J Endocrinol; 2000 Jul; 166(1):21-7. PubMed ID: 10856879
[TBL] [Abstract][Full Text] [Related]
16. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of acromegaly in a diabetic cat with transsphenoidal hypophysectomy.
Meij BP; Auriemma E; Grinwis G; Buijtels JJ; Kooistra HS
J Feline Med Surg; 2010 May; 12(5):406-10. PubMed ID: 20417901
[TBL] [Abstract][Full Text] [Related]
18. Feline acromegaly: a review of the syndrome.
Hurty CA; Flatland B
J Am Anim Hosp Assoc; 2005; 41(5):292-7. PubMed ID: 16141180
[TBL] [Abstract][Full Text] [Related]
19. Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen.
Trivedi P; Hindmarsh P; Risteli J; Risteli L; Mowat AP; Brook CG
J Pediatr; 1989 Feb; 114(2):225-30. PubMed ID: 2915282
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor I in cats: validation of an enzyme-linked immunosorbent assay and determination of biologic variation.
Strage EM; Theodorsson E; Ström Holst B; Lilliehöök I; Lewitt MS
Vet Clin Pathol; 2015 Dec; 44(4):542-51. PubMed ID: 26418310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
